| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-05-29 13:24:48 -0600 |
| HMDB ID |
HMDB00133 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Guanosine |
| Description |
Guanosine is a nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a beta-N9-glycosidic bond. Guanosine can be phosphorylated to become GMP (guanosine monophosphate), cGMP (cyclic guanosine monophosphate), GDP (guanosine diphosphate) and GTP (guanosine triphosphate). (Wikipedia). The nucleoside guanosine exert important neuroprotective and neuromodulator roles in the central nervous system, which may be related to inhibition of the glutamatergic neurotransmission activity. Guanosine is the specific extracellular guanine-based purines effector and indicate that its conversion occurs not only in the central nervous system but also peripherally. (PMID: 16325434 ). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 2-Amino-1,9-dihydro-9-b-D-ribofuranosyl-6H-purin-6-one
- 2-Amino-1,9-dihydro-9-beta-delta-ribofuranosyl-6H-purin-6-one
- 2-Amino-Inosine
- 9-b-D-Ribofuranosyl-Guanine
- 9-beta-delta-Ribofuranosyl-Guanine
- b-D-Ribofuranoside guanine-9
- beta-delta-Ribofuranoside guanine-9
- Guanosine
- Ribonucleoside
- Vernine
|
| Chemical Formula |
C10H13N5O5 |
| Average Molecular Weight |
283.2407 |
| Monoisotopic Molecular Weight |
283.091668551 |
| IUPAC Name |
2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one |
| Traditional IUPAC Name |
guanosine |
| CAS Registry Number |
118-00-3 |
| SMILES |
NC1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N1 |
| InChI Identifier |
InChI=1S/C10H13N5O5/c11-10-13-7-4(8(19)14-10)12-2-15(7)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19)/t3-,5-,6-,9-/m1/s1 |
| InChI Key |
NYHBQMYGNKIUIF-UUOKFMHZSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Nucleosides, Nucleotides, and Analogues |
| Class |
Purine Nucleosides and Analogues |
| Sub Class |
N/A |
| Other Descriptors |
- Aromatic Heteropolycyclic Compounds
- Ribonucleosides(KEGG)
- guanosines(ChEBI)
|
| Substituents |
- 1,2 Diol
- Aminopyrimidine
- Glycosyl Compound
- Hypoxanthine
- Imidazole
- Imidazopyrimidine
- N Glycosyl Compound
- Oxolane
- Pentose Monosaccharide
- Primary Alcohol
- Purine
- Purinone
- Pyrimidine
- Pyrimidone
- Saccharide
- Secondary Alcohol
|
| Direct Parent |
Purine Nucleosides and Analogues |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
Not Available
|
| Application |
Not Available
|
| Cellular locations |
- Extracellular
- Mitochondria
- Lysosome
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
239 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
0.7 mg/mL at 18 °C |
Not Available |
| LogP |
-1.90 |
SANGSTER (1993) |
|
| Predicted Properties |
|
| Spectra |
|
| 1H NMR Spectrum |
| 13C NMR Spectrum |
| MS/MS Spectrum Quattro_QQQ 10 |
| MS/MS Spectrum Quattro_QQQ 25 |
| MS/MS Spectrum Quattro_QQQ 40 |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| [1H,1H] 2D NMR Spectrum |
| [1H,13C] 2D NMR Spectrum |
|
| Biological Properties |
| Cellular Locations |
- Extracellular
- Mitochondria
- Lysosome
|
| Biofluid Locations |
- Blood
- Cellular Cytoplasm
- Urine
|
| Tissue Location |
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.8 +/- 0.5 uM |
Adult (>18 years old) |
Both |
Normal
|
|
| Cellular Cytoplasm |
Detected and Quantified |
|
4.5 +/- 2.9 uM |
Adult (>18 years old) |
Both |
Normal
|
|
| Urine |
Detected and Quantified |
|
0.13 (0.022-0.23) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal
|
|
| Urine |
Detected and Quantified |
|
0.06 +/- 0.02 umol/mmol creatinine |
Adult (>18 years old) |
Female |
Normal
|
|
| Urine |
Detected and Quantified |
|
0.05 +/- 0.02 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal
|
|
| Urine |
Detected and Quantified |
|
0.06 +/- 0.02 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal
|
|
|
| Abnormal Concentrations |
|
| Urine |
Detected and Quantified |
|
35.0 - 2588.0 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Purine-nucleoside phosphorylase (PNP; EC 2.4.2.1) deficiency.
|
|
| Urine |
Detected and Quantified |
|
35-588 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Purine-nucleoside phosphorylase deficiency
|
|
|
| Associated Disorders and Diseases |
| Disease References |
| Purine nucleoside phosphorylase deficiency |
- Wevers RA, Engelke UF, Moolenaar SH, Brautigam C, de Jong JG, Duran R, de Abreu RA, van Gennip AH: 1H-NMR spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism. Clin Chem. 1999 Apr;45(4):539-48.
Pubmed: 10102915
|
|
| Associated OMIM IDs |
- 164050
(Purine nucleoside phosphorylase deficiency )
|
| External Links |
| DrugBank ID |
DB02857  |
| DrugBank Metabolite ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB003632 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
6544  |
| KEGG Compound ID |
C00387  |
| BioCyc ID |
GUANOSINE  |
| BiGG ID |
51567  |
| Wikipedia Link |
Guanosine  |
| NuGOwiki Link |
HMDB00133  |
| Metagene Link |
HMDB00133  |
| METLIN ID |
87  |
| PubChem Compound |
6802  |
| PDB ID |
GMP  |
| ChEBI ID |
16750  |
| References |
| Synthesis Reference |
Tang, Shengrong; Huang, Weihong; Hou, Zuorong. Process of guanosine production by fermentation. Gongye Weishengwu (1998), 28(4), 11-16. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Lee SH, Jung BH, Kim SY, Chung BC: A rapid and sensitive method for quantitation of nucleosides in human urine using liquid chromatography/mass spectrometry with direct urine injection. Rapid Commun Mass Spectrom. 2004;18(9):973-7.
Pubmed: 15116424
- Wevers RA, Engelke UF, Moolenaar SH, Brautigam C, de Jong JG, Duran R, de Abreu RA, van Gennip AH: 1H-NMR spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism. Clin Chem. 1999 Apr;45(4):539-48.
Pubmed: 10102915
- Hartwick RA, Krstulovic AM, Brown PR: Identification and quantitation of nucleosides, bases and other UV-absorbing compounds in serum, using reversed-phase high-performance liquid chromatography. II. Evaluation of human sera. J Chromatogr. 1979 Dec 30;186:659-76.
Pubmed: 546939
- Traut TW: Physiological concentrations of purines and pyrimidines. Mol Cell Biochem. 1994 Nov 9;140(1):1-22.
Pubmed: 7877593
- Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4.
Pubmed: 19212411
- Saute JA, da Silveira LE, Soares FA, Martini LH, Souza DO, Ganzella M: Amnesic effect of GMP depends on its conversion to guanosine. Neurobiol Learn Mem. 2006 May;85(3):206-12. Epub 2005 Dec 1.
Pubmed: 16325434
|